Frank E. Thomas, Director at Larimar Therapeutics, Inc. (LRMR), bought 2,000 shares at $11.00 ($22K) on 2024-02-14, disclosed to the SEC on 2024-02-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AMAG | SELL | 2015-08-07 | $1.0M | — | Filing → |
| AMAG | SELL | 2015-06-08 | $1.4M | — | Filing → |
| AMAG | SELL | 2013-01-04 | $156K | — | Filing → |